Angiotensin II Type 1 Receptor Blockers: all 909 studies that test it
Page 7 of 10. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted ConditionsCompletedNCT01216852Not applicable
- Local Vasoconstriction in Postural Tachycardia SyndromeCompletedNCT01210430Early Phase 1
- Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular SchwannomaActive, not recruitingNCT01199978Phase 2
- Recurrent Stroke Prevention Clinical Outcome StudyStatus unknownNCT01198496Phase 4
- A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197014Phase 1
- A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197001Phase 1
- Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of CytochromesCompletedNCT01187862Phase 1
- Intensive Vasodilator Therapy in Patients With Essential HypertensionCompletedNCT01180413Phase 4
- Telmisartan, Amlodipine and Flow Mediated DilationStatus unknownNCT01180205Phase 4
- Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan SyndromeStatus unknownNCT01145612Phase 3
- The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionCompletedNCT01135212Phase 3
- The Confirmatory Olmesartan Plaque Regression StudyTerminatedNCT01132768Phase 4
- CKD-828 Primary Hypertension Trial(Dose-selection)CompletedNCT01128322Phase 2
- Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 HypertensionCompletedNCT01127217Phase 3
- Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential HypertensionCompletedNCT01122251Phase 2
- Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin SystemCompletedNCT01116180Not applicable
- A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy VolunteersCompletedNCT01115972Phase 1
- Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted ConditionsCompletedNCT01102478Not applicable
- Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive DiabeticsStatus unknownNCT01095822Phase 4
- Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure StudyWithdrawnNCT01089452Phase 4
- Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy VolunteersCompletedNCT01087749Phase 1
- A Trial of Telmisartan Prevention of Cardiovascular DiseaseCompletedNCT01075698Phase 4
- FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)CompletedNCT01071122Phase 4
- An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine DependenceCompletedNCT01062451Phase 1
- Anti-Fibrotic Effects of Losartan In Nash Evaluation StudyCompletedNCT01051219Phase 3
- The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis PatientsStatus unknownNCT01041963Phase 4
- Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)CompletedNCT01028534Not applicable
- Effect of Turmeric on Diabetic NephropathyCompletedNCT01015937Not applicable
- Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionCompletedNCT01012479Phase 4
- Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 DiabetesCompletedNCT01011062Not applicable
- Additive Effects of Pravastatin and ValsartanCompletedNCT01004237Phase 4
- Monotherapy Versus Dual Therapy for Initial Treatment for HypertensionStatus unknownNCT00994617Phase 4
- Irbesartan Versus Amlodipine: The OBI StudyWithdrawnNCT00987662Phase 4
- Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes MellitusCompletedNCT00982358Phase 4
- Development of Cocktail for Measuring the Activity of Important Cytochrome P450 EnzymesTerminatedNCT00981929Not applicable
- Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I HypertensionCompletedNCT00971165Phase 3
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyCompletedNCT00957554Phase 3
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg MonotherapyCompletedNCT00956644Phase 3
- Irbesartan and Amlodipine Combination in Controlling Blood PressureCompletedNCT00950066Phase 2
- Efficacy and Safety of Amlodipine and Losartan in Patients With Essential HypertensionCompletedNCT00942344Phase 2
- Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential HypertensionCompletedNCT00940680Phase 3
- Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential HypertensionCompletedNCT00940667Phase 3
- Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive PatientsCompletedNCT00939588Phase 2
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal AllograftsCompletedNCT00933231Phase 3
- Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis CWithdrawnNCT00930995Phase 2
- The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic SyndromeCompletedNCT00926341Phase 4
- The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With HypertensionCompletedNCT00921570Phase 4
- Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic NephropathyCompletedNCT00914524Phase 2
- Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific MealCompletedNCT00905333Phase 1
- Candesartan Versus Propranolol for Migraine PreventionCompletedNCT00884663Phase 2/3
- Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung CancerWithdrawnNCT00880386Not applicable
- Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic StrokeStatus unknownNCT00874601Phase 4
- Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00872586Phase 3
- Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsTerminatedNCT00863980Not applicable
- The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent ProteinuriaStatus unknownNCT00858299Phase 4
- The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)CompletedNCT00856960Phase 1
- Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential HypertensionCompletedNCT00856271Phase 3
- Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese PopulationCompletedNCT00847834Phase 4
- Bioequivalence Study in Healthy SubjectsCompletedNCT00844324Phase 1
- Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart FailureTerminatedNCT00843154Phase 3
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy SubjectsCompletedNCT00839683Phase 1
- Renin Profiling in Selection of Initial Antihypertensive DrugCompletedNCT00834600Not applicable
- Reducing the Overall Risk Level in Patients Suffering From Metabolic SyndromeCompletedNCT00821574Phase 4
- Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With TreatmentStatus unknownNCT00813722Phase 4
- Saving Residual Renal Function Among Haemodialysis Patients Receiving IrbesartanCompletedNCT00791830Phase 3
- Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)Status unknownNCT00790946Phase 4
- Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockersCompletedNCT00782327Phase 3
- Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.CompletedNCT00775840Phase 3
- Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.CompletedNCT00775814Phase 4
- Adiponectin and Insulin Resistance in Diabetic NephropathyCompletedNCT00774904Not applicable
- Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan SyndromeTerminatedNCT00763893Phase 3
- The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)CompletedNCT00754429Phase 4
- Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.CompletedNCT00750113Phase 4
- Regression of Fatty Heart by Valsartan TherapyWithdrawnNCT00745953Phase 4
- Role of AT1-receptor Blockers in Insulin-induced Vasodilation.Status unknownNCT00742066Not applicable
- Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentCompletedNCT00741585Phase 4
- Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With NephropathyCompletedNCT00738660Phase 3
- Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?Status unknownNCT00732966Not applicable
- Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)Status unknownNCT00732407Not applicable
- Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis PatientsCompletedNCT00721773Not applicable
- Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.CompletedNCT00720577Early Phase 1
- Telmisartan Versus Ramipril After Acute Coronary SyndromeStatus unknownNCT00702936Phase 4
- The Potential of Candesartan to Retard the Progression of Aortic StenosisStatus unknownNCT00699452Phase 3
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Status unknownNCT00699036Phase 2
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ DamageCompletedNCT00687206Phase 4
- Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan PatientsStatus unknownNCT00683124Phase 3
- Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionCompletedNCT00676845Phase 3
- Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive PatientsCompletedNCT00670566Phase 4
- Losartan and Simvastatin in Hypertensive Obeses With Liver SteatosisStatus unknownNCT00669435Phase 4
- Effects of Losartan on Insulin Resistance in Patients With Heart FailureCompletedNCT00663377Phase 4
- Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left VentricularStatus unknownNCT00659451Phase 3
- Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00649623Phase 1
- Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00648219Phase 1
- The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus SyndromeStatus unknownNCT00647257Not applicable
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)CompletedNCT00634712Phase 3
- Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)CompletedNCT00634400Phase 3
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)CompletedNCT00634309Phase 3
- Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal InsufficiencyTerminatedNCT00630708Not applicable
- Blood Pressure Lowering in Acute Stroke Trial (BLAST)WithdrawnNCT00627991Not applicable
- Irbesartan and Adhesion Molecules in AFStatus unknownNCT00613496Phase 4